Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD
-
Narrated by:
-
By:
Dr. Shuvro Roy talks with Dr. Michael Levy about satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy.
Read more about this abstract.
Disclosures can be found at Neurology.org.
adbl_web_anon_alc_button_suppression_t1
No reviews yet